Tacalyx

Developer of therapeutic agents for cancer treatment

placeBerlin, Berlin, Germany calendar_todayFounded 2018 groups9 employees language tacalyx.com

Registered entities

Social engagement

Social engagement: 2.8K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Kurma Partners, Thuja Capital.

Investor typeCountShare
Venture capital667%
Private equity222%
Other / undisclosed111%

Recent activity

14 Apr 2026
Event
AACR Annual Meeting
9 Apr 2026
Event
AACR Oncology Industry Partnering Event
23 Mar 2026
Event
BIO-Europe Spring
Coming soon